Controversial board move doesn’t stop StemCells from raising $20 million – San Francisco Business Times (blog)

Controversial board move doesn’t stop StemCells from raising $20 million
San Francisco Business Times (blog)
In the offering, StemCells will sell nearly 11.3 million shares of common stock as well as short-term warrants for the purchase of more than 9.6 million additional shares. The stock and warrants will be sold as units of one share of stock and a warrant
StemCells, Inc. Announces Proposed $20 Million OfferingMarketWatch

all 6 news articles

…read more

Scroll to Top